← Back to directory

Stephen B. Fox

Researcher Next ID · RN-033497

Researcher · Biochemistry, Genetics and Molecular Biology

Peter MacCallum Cancer Centre

Melbourne, Australia

Accepting doctoral researchersFunding unknown
Works count
814
Citation count
45,551
H-index
108
i10-index
390

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Cancer Genomics and Diagnostics
Breast Cancer Treatment Studies
Cancer Immunotherapy and Biomarkers
BRCA gene mutations in cancer
Angiogenesis and VEGF in Cancer

Publications

  • Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    npj Breast Cancer · 2020 · https://doi.org/10.1038/s41523-020-0156-0

  • The 2019 World Health Organization classification of tumours of the breast

    Histopathology · 2020 · https://doi.org/10.1111/his.14091

  • The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

    The Journal of Pathology · 2020 · https://doi.org/10.1002/path.5406

  • The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers in breast cancer clinical trials and daily practice

    The Journal of Pathology · 2020 · https://doi.org/10.1002/path.5406

  • Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    Advances in Anatomic Pathology · 2017 · https://doi.org/10.1097/pap.0000000000000162

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Advances in Anatomic Pathology · 2017 · https://doi.org/10.1097/pap.0000000000000161

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourina

    Advances in Anatomic Pathology · 2017 · https://doi.org/10.1097/pap.0000000000000161

  • Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group

    Modern Pathology · 2016 · https://doi.org/10.1038/modpathol.2016.109

  • UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas

    Cancer Research · 2015 · https://doi.org/10.1158/0008-5472.can-15-1877

  • Phyllodes tumours of the breast: a consensus review

    Histopathology · 2015 · https://doi.org/10.1111/his.12876

  • Lobular Neoplasia of the Breast Revisited With Emphasis on the Role of E-Cadherin Immunohistochemistry

    The American Journal of Surgical Pathology · 2013 · https://doi.org/10.1097/pas.0b013e3182918a2b

  • Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 / 2 (CIMBA)

    Cancer Epidemiology Biomarkers & Prevention · 2012 · https://doi.org/10.1158/1055-9965.epi-11-0775

  • BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group

    Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.39.8545

  • Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

    Modern Pathology · 2010 · 10.1038/modpathol.2010.200

  • Breast cancer prognostic classification in the molecular era: the role of histological grade

    Breast Cancer Research · 2010 · 10.1186/bcr2607

  • Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas

    Clinical Cancer Research · 2009 · https://doi.org/10.1158/1078-0432.ccr-08-1564

  • Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

    Clinical Cancer Research · 2008 · https://doi.org/10.1158/1078-0432.ccr-08-0196

  • Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

    Journal of Clinical Oncology · 2006 · 10.1200/jco.2006.05.9584

  • Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

    European Journal of Cancer · 1996 · 10.1016/s0959-8049(96)00379-6

Current projects

    No projects listed.